drugset / Trial / NCT03061981
A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects
RandomizedSequentialQuadruple-blindTreatment
Summary
This is a randomized, double blind, placebo controlled, single ascending dose study to assess the safety, tolerability, PK, PD and IE with metformin following a single oral dose of DA-1241 in healthy male subjects.
Timeline
- Start
- 2017-03-29
- Primary completion
- 2017-10-11
- Completion
- 2017-10-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DA-1241 | Unknown | — | Oral |
| Subject | Metformin | Small molecule | 500 mg | Oral |